Double-tracer dosimetry of organs in assessment of bone marrow involvement by two monoclonal antibodies

Acta Oncologica

Volumn 35, Issue 3, 1996, Pages 357-365

  Korppi Tommola, E Tapani ^a   Kairemo, Kalevi J A ^b   Jekunen, Antti P ^b   Niskanen, Eero O ^b   Savolainen, Sauli E ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY I 131; MONOCLONAL ANTIBODY TC 99M;

ADULT; AGED; BONE MARROW METASTASIS; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONFERENCE PAPER; DOSIMETRY; DRUG UPTAKE; FEMALE; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SCATTERING;

EID: 0029898573     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609101652     Document Type: Conference Paper

References (24)

1. 131I-labeled monoclonal antibody: an Illinois Cancer Council study. J Clin Oncol 1987; 5: 562-73.
2. 90Y-labelled monoclonal antibody in ovarian cancer. J Clin Oncol 1990; 8: 1941-50.
3. Kairemo KJA, Liewendahl K. Radioimmunodetection of malignant solid tumours. Scand J Clin Lab Invest 1994; 54: 569-83.
4. Plaizier MABD, Roos JC, Teule GJJ, et al. Comparison of non-invasive approaches to red marrow dosimetry for radiolabelled monoclonal antibodies. Eur J Nucl Med 1994; 21: 216-22.
5. Eary JF, Press OW, Badger CC, et al. Imaging and treatment of B-cell lymphoma. J Nucl Med 1990; 31: 1257-68.
6. m-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest. Nucl Med Commun 1992; 13: 55-60.
7. MacIntyre WJ, Saha GB, Go RT. Planar imaging with single-head large-field-of-view cameras: are they still the workhorse? Semin Nucl Med 1994; 24: 11-6.
8. O'Connell MEA, Flower MA, Hinton PJ, Harmer CL, McCready VR. Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET. Radiother Oncol 1993; 28: 16-26.
9. Flower MA, Schlesinger T, Hinton PJ, et al. Radiation dose assessment in radioiodine therapy. 2. Practical implementation using quantitative scanning and PET, with initial results on thyroid carcinoma. Radiother Oncol 1989: 15: 345-57.
10. 111In DTPA-D-Phe-octreotide in man assessed by whole body scintigraphy. Acta Radiol 1994; 35: 53-7.
11. Buijs WCAM, Massuger LFAG, Claessens RAMJ, Kenemans P, Corstens FHM. Dosimetric evaluation of immunoscintigraphy using indium-111-labeled monoclonal antibody fragments in patients with ovarian cancer. J Nucl Med 1992; 33: 1113-20.
12. Taube T, Elomaa I, Blomqvist C, Beneton MNC, Kanis JA. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone 1994; 15: 161-6.
13. Duncker CM, Carrió I, Berná L, et al. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med 1990; 31: 1450-5.
14. Rieker O, Grünwald F, Layer G, et al. Disseminated bone marrow metastases from primary breast cancer: Detection and follow-up by radioimmune bone marrow scintigraphy. J Nucl Med 1994; 35: 1485-7.
15. Snyder WS, Fisher Jr HL, Ford MR, Warner GG. Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. MIRD Pamphlet no 5. J Nucl Med 1969; 10 (Suppl 3): 7-52.
16. MIRDOSE 3. Radiation Internal Dose Information Center, Oak Ridge Institute for Science and Education. P.O. Box 117, Oak Ridge, TN 37831, USA.
17. m-nanocolloid bone marrow scintigraphy in prostatic cancer. Br J Urol 1989; 63: 497-502.
18. Bourgeois P, Gassavelis C, Malarme M, Feremans W, Frühling J. Bone marrow scintigraphy in breast cancer. Nucl Med Commun 1989; 10: 389-400.
19. Sacchi S, Marietta M, Rinaldi D, et al. Bone and bone marrow scintigraphy in the diagnosis of metasplastic involvement of the skeletal system. J Nucl Med All Sci 1987; 31: 255-60.
20. Vogler III JB, Murphy WA. Bone marrow imaging. Radiology 1988; 168: 679-93.
21. Reske SN, Karstens JH, Gloeckner W, et al. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet 1989; 1: 299-301.
22. Carpani de Kaski M, Peters AM, Knight D, Stuttle AWJ, Lavender JP, Hodgson HJ. Indium-111 whole-body retention: a method for quantification of disease activity in inflammatory bowel disease. J Nucl Med 1992; 33: 756-62.
23. Peters AM. The utility of [99mTc]HMPAO-leukocytes for imaging infection. Semin Nucl Med 1994; 24: 110-27.
24. Meredith RF, Khazaeli MB, Plott WE, et al. Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer. J Nucl Med 1992; 33: 23-9.